NDC 68788-8797-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8797
- Requested NDC
- 68788-8797-01
- Package NDCs from labels
- 68788-8797-7, 68788-8797-5, 68788-8797-2, 68788-8797-3, 68788-8797-4, 68788-8797-6, 68788-8797-9, 68788-8797-1, 68788-8797-8, 68788-8797-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-01-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8797-1 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 68788-8797-2 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 2 | |
| 68788-8797-3 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 68788-8797-4 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 2 | |
| 68788-8797-5 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 2 | |
| 68788-8797-6 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 68788-8797-7 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 2 | |
| 68788-8797-8 | Naproxen | 120 in 1 BOTTLE | TABLET | 120 | 2 | |
| 68788-8797-9 | Naproxen | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8797 | NAPROXEN TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 9 package rows | 20250101_87acd650-ea8a-4396-be72-5568c4b1755c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8797-1 | EA - Each | 68788-8797 | 159fe6cc-3dbe-4664-91d2-bd901bce8b54 | 1 | 2025-02-10 |
| 68788-8797-2 | EA - Each | 68788-8797 | 4dd0d4b6-e123-46e3-a444-dbec5f7efc6f | 1 | 2025-02-10 |
| 68788-8797-3 | EA - Each | 68788-8797 | c86c8a81-8b94-41ae-a0f6-c8d4de2c5eb3 | 1 | 2025-02-10 |
| 68788-8797-4 | EA - Each | 68788-8797 | b594bf0f-d195-494c-9953-4e70aab7f870 | 1 | 2025-02-10 |
| 68788-8797-5 | EA - Each | 68788-8797 | 5c6a5378-8358-46e0-a7fa-ab8f65b9657c | 1 | 2025-02-10 |
| 68788-8797-6 | EA - Each | 68788-8797 | f9ff93b9-c195-4959-a827-48ac4beb2e63 | 1 | 2025-02-10 |
| 68788-8797-7 | EA - Each | 68788-8797 | a979fbbf-d6c0-43ae-b53b-6ee876fbd3d6 | 1 | 2025-02-10 |
| 68788-8797-8 | EA - Each | 68788-8797 | 9f519631-77c6-4783-9fc3-a448a97d2518 | 1 | 2025-02-10 |
| 68788-8797-9 | EA - Each | 68788-8797 | 1ee7a67a-6eea-4502-874a-d8ededa3e837 | 1 | 2025-02-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium | NAPROXEN SODIUM | Upsher-Smith Laboratories, LLC | 7c22a2d6-821c-4f83-aead-e756aed930e5 | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 9TN87S3A3C |
| Naproxen | NAPROXEN | A-S Medication Solutions | f856d3ff-7e70-4c5a-98fb-76d8af6adb46 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | d8726a3f-03d5-4a5a-a780-f760faaaecf3 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Granules Pharmaceuticals Inc. | c1cb9bb9-fbae-5e5c-e053-2995a90a0d21 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN SODIUM | Granules India Ltd | 1f8da545-bcfe-4c22-a9f1-d34108120aa0 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 9TN87S3A3C |
| Naproxen Sodium and Diphenhydramine HCl | NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL | Granules India Ltd | 0d59780a-ef22-4b67-8b42-9795dbec8db0 | 2026-10-07 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN SODIUM | NuCare Pharmaceuticals,Inc. | f1ed8384-83d6-6f2a-e053-2a95a90ab08f | 2026-10-07 | Warnings | 9TN87S3A3C |
| naproxen sodium | NAPROXEN SODIUM | Bionpharma Inc. | ba4f927a-4bbe-0d87-e053-2995a90a8c20 | 2026-10-05 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | St. Mary's Medical Park Pharmacy | 5de3af7c-2c77-6b04-e053-2991aa0ae3fa | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | TruPharma LLC | 004bb832-29d5-add0-e063-6394a90a90f4 | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN SODIUM | Amerisource Bergen | 1e2e6e3a-b095-4d5b-86fe-61eb44a87cf0 | 2026-10-01 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Unit Dose Solutions, Inc. | 5ca1d392-ee02-3ce3-e063-6394a90a7827 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Topco Associates LLC | af314adb-bd65-4233-b7e1-6cfb819615a3 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO-TOUCH | Walgreens Company | 33219878-f102-46c6-bd63-e83d54fa2785 | 2026-09-25 | Warnings | 1K09F3G675 |
| Naproxen | NAPROXEN | American Health Packaging | 86a3e612-3bfe-432f-9afd-972bb8a6644e | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Sinus and Cold D | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 9e142ac7-c8b1-449b-a224-c7db0fc0e4cf | 2026-09-24 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | A-S Medication Solutions | bce23087-f055-4234-b75d-69dd43233190 | 2026-09-23 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198012 57Y76R9ATQ |
| Calamine | CALAMINE, PRAMOXIND HCL | Nice-Pak Products, LLC | 9089e23e-ca4a-454f-8dcc-ff5a29a5a335 | 2026-09-22 | Warnings, Adverse reactions | 1K09F3G675 |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| Calamine | CALAMINE, ZINC OXIDE | Nice-Pak Products, LLC | c370ee1f-1887-44e8-8d47-8ffa3c270ff5 | 2026-09-15 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.